about
Fatty acid metabolites in rapidly proliferating breast cancer15-lipoxygenase metabolites of docosahexaenoic acid inhibit prostate cancer cell proliferation and survivalEnhanced formation of 5-oxo-6,8,11,14-eicosatetraenoic acid by cancer cells in response to oxidative stress, docosahexaenoic acid and neutrophil-derived 5-hydroxy-6,8,11,14-eicosatetraenoic acidAdvances in Our Understanding of Oxylipins Derived from Dietary PUFAs5-Oxo-ETE and the OXE receptorBiosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acidOmega-3 Fatty Acids and PPARgamma in CancerThe eosinophil chemoattractant 5-oxo-ETE and the OXE receptorUpdate on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7Cell survival signalling through PPARδ and arachidonic acid metabolites in neuroblastomaAntagonizing effects of membrane-acting androgens on the eicosanoid receptor OXER1 in prostate cancerNovel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-γ.15-oxo-Eicosatetraenoic acid, a metabolite of macrophage 15-hydroxyprostaglandin dehydrogenase that inhibits endothelial cell proliferationPeroxisome proliferator-activated receptor-γ agonist inhibits collagen synthesis in human keloid fibroblasts by suppression of early growth response-1 expression through upregulation of miR-543 expression.PPAR gamma, bioactive lipids, and cancer progression.Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System.Patent Highlights October-November 2016.
P2860
Q21090755-D2FC6BC1-95FC-4B22-8746-C826DCB359F0Q21134042-B9DB6888-74AD-44D9-A14F-696613BB911EQ24626940-E813421E-3B4D-4FC5-B8E9-C229FEE92426Q27014988-4EF184C8-8172-4B8F-8E46-90470EDFFC08Q28245381-CB82D953-7992-4614-B0CB-A02CD4B517F6Q28252674-9C2B2D4A-1828-400E-8FD5-3AA0A158510BQ28292907-C37CEA73-D80A-4F10-B5F3-B61CC647A570Q28298968-F8232D47-7C17-49AF-AF3B-5C6186775239Q28308192-29F1173C-56EE-4A45-89E8-2740E117316BQ28534569-B658050B-8298-47FC-B8B1-EE168AF22186Q30360857-37A19F46-E597-4D32-9792-8A7F2659327BQ30573092-2CAE041E-95BE-4D67-8B5B-6C6D14C31E5EQ34987471-FC941DF8-45D6-465C-AFEB-A6767430A8B6Q37077414-5338904B-1FD9-4AB1-A397-C834CE3DECC0Q37971590-D219CC54-05E3-4449-A70D-73CEF0B477B4Q48226915-C2F020D6-63C6-404A-983C-5CBE55C6F039Q54380711-463972EE-7190-48E3-8BB7-B180C2238C11
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
5-Oxo-ETE analogs and the proliferation of cancer cells
@ast
5-Oxo-ETE analogs and the proliferation of cancer cells
@en
5-Oxo-ETE analogs and the proliferation of cancer cells
@nl
type
label
5-Oxo-ETE analogs and the proliferation of cancer cells
@ast
5-Oxo-ETE analogs and the proliferation of cancer cells
@en
5-Oxo-ETE analogs and the proliferation of cancer cells
@nl
prefLabel
5-Oxo-ETE analogs and the proliferation of cancer cells
@ast
5-Oxo-ETE analogs and the proliferation of cancer cells
@en
5-Oxo-ETE analogs and the proliferation of cancer cells
@nl
P2093
P1476
5-Oxo-ETE analogs and the proliferation of cancer cells
@en
P2093
Anuradha Rao
Carl E Clay
Charles S Morrow
Christian M Paumi
Joseph T O'Flaherty
Kevin High
Lance R Thomas
LeAnn C Rogers
Mark C Willingham
Pamela K Smitherman
P304
P356
10.1016/J.BBALIP.2005.08.009
P407
P577
2005-10-01T00:00:00Z